THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM
Total 13F shares
123,989,841
Share change
-8,893,023
Total reported value
$44,113,283
Put/Call ratio
54%
Price per share
$0.36
Number of holders
118
Value change
-$5,136,500
Number of buys
36
Number of sells
84

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q4 2021

As of 31 Dec 2021, THERAPEUTICSMD INC - COM (TXMD) was held by 118 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 123,989,841 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, FMR LLC, MORGAN STANLEY, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, C WorldWide Group Holding A/S, AMERIPRISE FINANCIAL INC, Rubric Capital Management LP, and NORTHERN TRUST CORP. This page lists 118 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.